Optimizing Maternal and Fetal Antibody Exposure and Dosing Regimens During Pregnancy Using a Physiologically Based Pharmacokinetic Model

Documenti analoghi

• Antibody Transfer From Mother to Fetus/Infant: An Opportunity for Model‐Informed Precision Medicine
  di: Miramar Sami Kardouh, et al.
  Pubblicazione: (2025)
• Predicting Maternal and Fetal Exposures of Elexacaftor–Tezacaftor–Ivacaftor during Pregnancy through Physiologically Based Pharmacokinetic Models
  di: Eunjin Hong, et al.
  Pubblicazione: (2025)
• Pharmacokinetics and Exposure–Response Analyses to Support Dose Selection of Upadacitinib in Crohn's Disease
  di: Sumit Bhatnagar, et al.
  Pubblicazione: (2024)
• Congenital and Fetal Effects After Mifepristone Exposure and Continuation of Pregnancy: A Systematic Review
  di: Joseph V. Turner, et al.
  Pubblicazione: (2024)
• Personalized Chronomodulated 5‐Fluorouracil Treatment: A Physiologically‐Based Pharmacokinetic Precision Dosing Approach for Optimizing Cancer Therapy
  di: Fatima Zahra Marok, et al.
  Pubblicazione: (2024)